Narayana Hrudayalaya: Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026
Narayana Hrudayalaya (NH) filed a disclosure titled "Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026". The company is valued at about ₹35,154 crore.
What happened
Narayana Hrudayalaya (NH) filed a disclosure with the exchanges on 30 October 2026 at 06:41 PM titled "Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026".
Company snapshot
Narayana Hrudayalaya is a mid-cap company in the Healthcare sector, with a market value of about ₹35,154 crore.
The stock last traded at ₹1,720.2, against a 52-week range of ₹1,589–₹2,093.3 (17.8% below the high).
Before this filing the shares had moved −5.8% over the month and −17.6% over three months. Average daily turnover over the last 20 sessions was about ₹25.19 crore.
Promoters held 63.27% at the end of Q1 FY27. Foreign institutions owned 9.40% and domestic institutions 9.06%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1,507 | 196.7 | 9.68 |
| Q2 FY26 | 1,644 | 258.4 | 12.72 |
| Q3 FY26 | 2,151 | 126.7 | 6.24 |
| Q4 FY26 | 2,594 | 223.9 | 11.02 |
| Q1 FY27 | 2,684 | 207.2 | 10.2 |
What history shows
This is not the company's first results disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 5.4% on average the next trading day and was down 9.6% on average after five days (2 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.1% on average the next day and +2.0% over five days; 56% of them rose the next day.
Market-wide, 10,043 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 31 Jul 2026 | Unaudited Financial Results (Standalone And Consolidated) For The… | −5.4% | −9.6% |
| 31 Jul 2026 | Board Meeting Outcome for Outcome Of The Board Meeting For Unaudited… | −5.4% | −9.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 30 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.